Research brief · 2026-09-09
Does BPC-157 Do Anything for Muscle?
BPC-157 is a synthetic fifteen-amino-acid peptide, a fragment of a protein found in human gastric juice. It is not approved for human use, and almost everything known about it and muscle comes from rats.
Within that animal literature the muscle findings are consistent. Staresinic and colleagues in the Journal of Orthopaedic Research in 2006 completely transected the quadriceps muscle in rats, an injury that does not heal well on its own. Over seventy-two days, treated rats showed higher load-to-failure, better walking and motor scores, and muscle fibres reconnecting across the injury. A 2019 review by Gwyer and colleagues in Cell and Tissue Research summarised the effects as consistently positive across injury types, and stated that efficacy in humans is yet to be confirmed.
The human record is close to empty. A 2025 scoping review by McGuire and colleagues in Current Reviews in Musculoskeletal Medicine identified only three pilot studies of BPC-157 in humans for any condition: intra-articular knee pain, interstitial cystitis, and an intravenous safety and pharmacokinetics study. None tested a muscle outcome. The reviewers reported no adverse effects in those small studies but concluded the compound should be considered investigational until rigorous trials exist.
A 2026 scoping review by Tewari and colleagues in The American Journal of Sports Medicine searched for musculoskeletal research on BPC-157 and five other emerging peptides. Sixty-seven percent of publications used animal models, mostly rats. Where human data existed, the reviewers called it heterogeneous, showing modest improvements at best, from studies that mostly lacked robust controls.
So the specific question has no direct human evidence in either direction. It is not that trials found no effect; trials measuring a muscle effect in people do not appear to exist. Animal results cannot simply be assumed to carry over. Anyone with a muscle injury should talk to a physician about treatments that have actually been tested.
Sources
- Staresinic M, Petrovic I, Novinscak T, et al. Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157
- Journal of Orthopaedic Research 2006
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
- Cell and Tissue Research 2019
- McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
- Current Reviews in Musculoskeletal Medicine 2025
- Tewari K, Liu TP, Im C, et al. Peptide Supplements and Their Therapeutic Applications in Sports Medicine
- The American Journal of Sports Medicine 2026
Peptide Proof reports what studies found. We do not give medical advice, dosing guidance, or treatment recommendations.